Add like
Add dislike
Add to saved papers

Early cognitive impairment at acute stage after intracerebral hemorrhage.

BACKGROUND: The cognitive impairment after acute intracerebral hemorrhage (ICH) is common. While, the evidence of early cognitive impairment at acute stage after ICH are limited. We determined the frequency and risk factors of early cognitive impairment at acute stage and investigated its association with delayed cognitive impairment after ICH.

METHODS: A total of 208 patients with acute ICH were enrolled from January 2017 to February 2019. Cognitive function was assessed during the acute stage and at follow-up using Montreal Cognitive Assessment (MoCA) score. Significant cognitive impairment was defined as having a MoCA score &20 at the acute stage (within 1 week after hospital admission) or during follow up.

RESULTS: The mean observation period was 20 (IQC 17-23) months, and follow-up cognitive function data were collected from 185 patients. 89 (42.8%) and 86 (46.5%) patients had acute stage and delayed significant cognitive impairment respectively. Older age, large baseline hematoma volume, more severe ICH, and low level of education were significantly associated with significant cognitive impairment at acute stage (all P<0.009). In the multivariable logistic regression model, the low MoCA score (odds ratio [OR] 0.59; 95% confidence interval [CI] 0.48-0.71; P<0.001) at acute stage was independently associated with delayed significant cognitive impairment after ICH.

CONCLUSIONS: Near half of the patients had significant cognitive impairment at acute stage after ICH. Cognitive impairment is more frequent in the elderly, those with large baseline hematoma volume, and more severe initial neurological deficit. Having a lower MoCA score during the acute phase was independently associated with increased risk of delayed cognitive impairment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app